| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,207 |
10,863 |
$943K |
| 99199 |
Unlisted special service, procedure or report |
71,899 |
31,554 |
$344K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,403 |
2,701 |
$311K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,013 |
1,640 |
$180K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,854 |
1,551 |
$171K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,869 |
1,460 |
$155K |
| 99401 |
|
3,937 |
2,694 |
$125K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,859 |
2,274 |
$85K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,744 |
3,667 |
$83K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
593 |
505 |
$59K |
| D0145 |
Oral evaluation for a patient under three years of age |
1,200 |
982 |
$40K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
735 |
552 |
$25K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,895 |
905 |
$25K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,461 |
1,998 |
$23K |
| D1206 |
Topical application of fluoride varnish |
1,199 |
981 |
$17K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
372 |
319 |
$13K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
274 |
165 |
$10K |
| 96127 |
|
1,258 |
1,019 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
679 |
547 |
$9K |
| 90474 |
|
427 |
346 |
$7K |
| 96161 |
|
958 |
745 |
$3K |
| 92551 |
|
3,921 |
3,234 |
$3K |
| 90651 |
|
106 |
89 |
$2K |
| 99173 |
|
3,916 |
3,230 |
$1K |
| 0071A |
|
31 |
15 |
$1K |
| 0072A |
|
20 |
15 |
$975.99 |
| 87807 |
|
86 |
61 |
$832.25 |
| 90686 |
|
857 |
611 |
$711.10 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
19 |
15 |
$347.13 |
| 90734 |
|
17 |
13 |
$295.48 |
| 85018 |
|
131 |
88 |
$273.96 |
| G9919 |
Screening performed and positive and provision of recommendations |
21 |
16 |
$156.50 |
| 83655 |
|
66 |
39 |
$43.36 |
| 90633 |
|
199 |
154 |
$33.52 |
| 90713 |
|
16 |
14 |
$32.15 |
| 90680 |
|
488 |
389 |
$0.00 |
| 90698 |
|
693 |
573 |
$0.00 |
| 90677 |
|
234 |
206 |
$0.00 |
| 90744 |
|
219 |
169 |
$0.00 |
| 36416 |
|
94 |
65 |
$0.00 |
| 90656 |
|
86 |
72 |
$0.00 |
| 90381 |
|
15 |
12 |
$0.00 |
| 91307 |
|
72 |
53 |
$0.00 |
| 90619 |
|
37 |
28 |
$0.00 |
| 90700 |
|
153 |
126 |
$0.00 |
| 90670 |
|
1,125 |
865 |
$0.00 |
| 90685 |
|
13 |
13 |
$0.00 |
| 90710 |
|
189 |
142 |
$0.00 |